 |
PDBsum entry 1nx2
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Calpain domain vi
|
|
Structure:
|
 |
Calcium-dependent protease, small subunit. Chain: a. Fragment: domain vi. Synonym: calpain regulatory subunit, calcium-activated neutral proteinase, canp. Engineered: yes
|
|
Source:
|
 |
Sus scrofa. Pig. Organism_taxid: 9823. Gene: capns1 or capn4. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.221
|
R-free:
|
0.264
|
|
|
Authors:
|
 |
B.Todd,D.Moore,C.C.S.Deivanayagam,G.-D.Lin,D.Chattopadhyay,M.Maki, K.K.W.Wang,S.V.L.Narayana
|
Key ref:
|
 |
B.Todd
et al.
(2003).
A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
J Mol Biol,
328,
131-146.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Feb-03
|
Release date:
|
19-Aug-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04574
(CPNS1_PIG) -
Calpain small subunit 1 from Sus scrofa
|
|
|
|
Seq: Struc:
|
 |
 |
 |
266 a.a.
173 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
328:131-146
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
|
|
B.Todd,
D.Moore,
C.C.Deivanayagam,
G.D.Lin,
D.Chattopadhyay,
M.Maki,
K.K.Wang,
S.V.Narayana.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Ca(2+)-dependent cysteine protease calpain along with its endogenous
inhibitor calpastatin is widely distributed. The interactions between calpain
and calpastatin have been studied to better understand the nature of calpain
inhibition by calpastatin, which can aid the design of small molecule inhibitors
to calpain. Here we present the crystal structure of a complex between a
calpastatin peptide and the calcium-binding domain VI of calpain. DIC19 is a 19
residue peptide, which corresponds to one of the three interacting domains of
calpastatin, which is known to interact with domain VI of calpain. We present
two crystal structures of DIC19 bound to domain VI of calpain, determined by
molecular replacement methods to 2.5A and 2.2A resolution. In the process of
crystallizing the inhibitor complex, a new native crystal form was identified
which had the homodimer 2-fold axis along a crystallographic axis as opposed to
the previously observed dimer in the asymmetric unit. The crystal structures of
the native domain VI and its inhibitor PD150606
(3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid) complex were determined with
the help of molecular replacement methods to 2.0A and 2.3A resolution,
respectively. In addition, we built a homology model for the complex between
domain IV and DIA19 peptide of calpastatin. Finally, we present a model for the
calpastatin-inhibited calpain.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Ribbon representation of the domain VI crystal
structure. (a) Stereographic Ribbon diagrams of the domain VI
monomer present in the asymmetric unit. The bound calcium atoms
are represented as silver colored spheres. Helices are labeled
according to their EF-hand numbering ranging from EF1 to EF5,
respectively. The bound DIC19 peptide in helical conformation is
represented in yellow and the "mysterious peptide" appeared in
the same location as observed in ALG-2 crystal structure[52.] is
presented in purple. (b) Ribbon representation of the DVI dimer,
depicting interactions through the crystallographic 2-fold axis.
|
 |
Figure 5.
Figure 5. Stereo view of the surface plots of the
hydrophobic inhibitor binding sites. (a) The DIC19 binding
region in calcium-bound DVI. DIC19, represented as a helical
segment, yellow in color, clearly displays its amphipathic
nature with its bulky hydrophobic side-chains buried deep into
DVI and polar residues exposed to the solvent (side-chains
removed for clarity). (b) Bulky hydrophobic ring of the
inhibitor PD150606 and Phe610 of DIC19 occupy the same region of
DVI. However, the hydrophobic region that accommodates these
inhibitor molecules seems to be flexible enough, varying in size
to accommodate different sized inhibitors. c) View of the
inhibitor binding regions in the calcium-free DVI structure.
DIC19 is positioned in the same place, as in previous Figures,
indicating the narrowness of the hydrophobic region.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2003,
328,
131-146)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.J.Storr,
N.O.Carragher,
M.C.Frame,
T.Parr,
and
S.G.Martin
(2011).
The calpain system and cancer.
|
| |
Nat Rev Cancer,
11,
364-374.
|
 |
|
|
|
|
 |
A.Drewniak,
B.J.van Raam,
J.Geissler,
A.T.Tool,
O.R.Mook,
T.K.van den Berg,
F.Baas,
and
T.W.Kuijpers
(2009).
Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating factor/dexamethasone mobilization for transfusion purposes.
|
| |
Blood,
113,
5979-5998.
|
 |
|
|
|
|
 |
J.D.Johnson,
K.Otani,
G.I.Bell,
and
K.S.Polonsky
(2009).
Impaired insulin secretion in transgenic mice over-expressing calpastatin in pancreatic β-cells.
|
| |
Islets,
1,
242-248.
|
 |
|
|
|
|
 |
O.Toke,
Z.Bánóczi,
G.Tárkányi,
P.Friedrich,
and
F.Hudecz
(2009).
Folding transitions in calpain activator peptides studied by solution NMR spectroscopy.
|
| |
J Pept Sci,
15,
404-410.
|
 |
|
|
|
|
 |
D.E.Croall,
L.M.Vanhooser,
and
R.E.Cashon
(2008).
Detecting the active conformation of calpain with calpastatin-based reagents.
|
| |
Biochim Biophys Acta,
1784,
1676-1686.
|
 |
|
|
|
|
 |
J.Pfizer,
I.Assfalg-Machleidt,
W.Machleidt,
and
N.Schaschke
(2008).
Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
|
| |
Biol Chem,
389,
83-90.
|
 |
|
|
|
|
 |
R.A.Hanna,
R.L.Campbell,
and
P.L.Davies
(2008).
Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
|
| |
Nature,
456,
409-412.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Moldoveanu,
K.Gehring,
and
D.R.Green
(2008).
Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
|
| |
Nature,
456,
404-408.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.E.Croall,
and
K.Ersfeld
(2007).
The calpains: modular designs and functional diversity.
|
| |
Genome Biol,
8,
218.
|
 |
|
|
|
|
 |
I.M.Medana,
N.P.Day,
T.T.Hien,
N.T.Mai,
D.Bethell,
N.H.Phu,
G.D.Turner,
J.Farrar,
N.J.White,
and
M.M.Esiri
(2007).
Cerebral calpain in fatal falciparum malaria.
|
| |
Neuropathol Appl Neurobiol,
33,
179-192.
|
 |
|
|
|
|
 |
M.Bokor,
V.Csizmók,
D.Kovács,
P.Bánki,
P.Friedrich,
P.Tompa,
and
K.Tompa
(2005).
NMR relaxation studies on the hydrate layer of intrinsically unstructured proteins.
|
| |
Biophys J,
88,
2030-2037.
|
 |
|
|
|
|
 |
A.Wendt,
V.F.Thompson,
and
D.E.Goll
(2004).
Interaction of calpastatin with calpain: a review.
|
| |
Biol Chem,
385,
465-472.
|
 |
|
|
|
|
 |
B.G.Diaz,
T.Moldoveanu,
M.J.Kuiper,
R.L.Campbell,
and
P.L.Davies
(2004).
Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide.
|
| |
J Biol Chem,
279,
27656-27666.
|
 |
|
|
|
|
 |
L.Subramanian,
J.W.Crabb,
J.Cox,
I.Durussel,
T.M.Walker,
P.R.van Ginkel,
S.Bhattacharya,
J.M.Dellaria,
K.Palczewski,
and
A.S.Polans
(2004).
Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.
|
| |
Biochemistry,
43,
11175-11186.
|
 |
|
|
|
|
 |
Y.Ono,
K.Kakinuma,
F.Torii,
A.Irie,
K.Nakagawa,
S.Labeit,
K.Abe,
K.Suzuki,
and
H.Sorimachi
(2004).
Possible regulation of the conventional calpain system by skeletal muscle-specific calpain, p94/calpain 3.
|
| |
J Biol Chem,
279,
2761-2771.
|
 |
|
|
|
|
 |
D.Mitchell,
and
A.Bell
(2003).
PEST sequences in the malaria parasite Plasmodium falciparum: a genomic study.
|
| |
Malar J,
2,
16.
|
 |
|
|
|
|
 |
Z.Mucsi,
F.Hudecz,
M.Hollósi,
P.Tompa,
and
P.Friedrich
(2003).
Binding-induced folding transitions in calpastatin subdomains A and C.
|
| |
Protein Sci,
12,
2327-2336.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |